Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Bullous amyloidosis complicated by cellulitis and sepsis: a case report.

Reddy K, Hoda S, Penstein A, Wasil T, Chen S.

Arch Dermatol. 2011 Jan;147(1):126-7. doi: 10.1001/archdermatol.2010.381. No abstract available.

PMID:
21242410
2.

Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia.

Kaufman MS, Caramanica A, Janson D, Driscoll N, Johnson C, Kohn N, Wasil T, Rai KR.

Med Oncol. 2011 Jun;28(2):532-8. doi: 10.1007/s12032-010-9478-3. Epub 2010 Mar 17.

PMID:
20237867
3.

Fine needle aspiration of pulmonary adiaspiromycosis: a case report.

Sun Y, Bhuiya T, Wasil T, Macias A, Wasserman PG.

Acta Cytol. 2007 Mar-Apr;51(2):217-21.

PMID:
17425208
4.

Treatment of elderly cancer patients with chemotherapy.

Wasil T, Lichtman SM.

Cancer Invest. 2005;23(6):537-47. Review.

PMID:
16203662
5.
6.

Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.

Messmer D, Telusma G, Wasil T, Messmer BT, Allen S, Rai KR, Chiorazzi N.

Mol Med. 2004 Jul-Dec;10(7-12):96-103.

7.

Survival of chronic lymphocytic leukemia cells: CD40L and the vascular endothelial growth factor (VEGF) connection.

Kay NE, Wasil T.

Leukemia. 2005 Apr;19(4):531-2. Review. No abstract available.

PMID:
15861177
8.

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D, Murphy EJ, Koduru P, Ferrarini M, Zupo S, Cutrona G, Damle RN, Wasil T, Rai KR, Hellerstein MK, Chiorazzi N.

J Clin Invest. 2005 Mar;115(3):755-64.

9.

Clinical staging and prognostic markers in chronic lymphocytic leukemia.

Rai KR, Wasil T, Iqbal U, Driscoll N, Patel D, Janson D, Mehrotra B.

Hematol Oncol Clin North Am. 2004 Aug;18(4):795-805, vii. Review.

PMID:
15325699
10.

The role of monoclonal antibodies in stem cell transplantation.

Wasil T, Rai KR, Mehrotra B.

Semin Oncol. 2004 Feb;31(1):83-9. Review.

PMID:
14970940
11.

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.

Damle RN, Batliwalla FM, Ghiotto F, Valetto A, Albesiano E, Sison C, Allen SL, Kolitz J, Vinciguerra VP, Kudalkar P, Wasil T, Rai KR, Ferrarini M, Gregersen PK, Chiorazzi N.

Blood. 2004 Jan 15;103(2):375-82. Epub 2003 Sep 22.

12.

Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation.

Damle RN, Fais F, Ghiotto F, Valetto A, Albesiano E, Wasil T, Batliwalla FM, Allen SL, Schulman P, Vinciguerra VP, Rai KR, Gregersen PK, Ferrarini M, Chiorazzi N.

Curr Top Microbiol Immunol. 2000;252:285-92. No abstract available.

PMID:
11125486
13.

Gene therapy in human cancer: report of human clinical trials.

Wasil T, Buchbinder A.

Cancer Invest. 2000;18(8):740-6. Review. No abstract available.

PMID:
11107444
14.

Radiation therapy in cancer patients 80 years of age and older.

Wasil T, Lichtman SM, Gupta V, Rush S.

Am J Clin Oncol. 2000 Oct;23(5):526-30.

PMID:
11039517
15.

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N.

Blood. 1999 Sep 15;94(6):1840-7.

16.
17.

Probable transfusion-associated graft-versus-host disease in a patient with tuberous sclerosis.

Asnis DS, Wasil T, Chaudri F, Kuan J.

South Med J. 1996 Apr;89(4):446-8.

PMID:
8614894

Supplemental Content

Support Center